Sort
23,748 grants matching “melanoma”
Innovative solutions to spatial uncertainty in geocoding
$377,438Myles G Cockburn · University Of Southern California · R01 · FY2015 · CA
PAX3 pathways in melanoma
$377,438Deborah Lang · Boston University Medical Campus · R01 · FY2018 · CA
Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL
$377,438Michael W Deininger · Versiti Blood Health, Inc. · R01 · FY2025 · CA
Mechanism of Retinal Damage in Autoimmune Retinopathy
$377,389Grazyna Adamus · Oregon Health & Science University · R01 · FY2006 · EY
Project 2: Dual Targeting of B7-H3 in mCRPC
$377,386Kenneth J. Pienta · Johns Hopkins University · P50 · FY2025 · CA
In situ radioimmunotherapy to maximize the engagement of conventional type 1 dendritic cells against non-T cell-inflamed tumors
$377,327Fumito Ito · University Of Southern California · R01 · FY2024 · CA
The Role of Ets1 in Melanocyte Development
$377,313Lidia Kos · Florida International University · R15 · FY2012 · AR
USP18 in Cancer Development
$377,288Dong-Er Zhang · University Of California, San Diego · R01 · FY2020 · CA
Development of therapeutic chemokine-based formulations
$377,262Arya Biragyn · National Institute On Aging · ZIA · FY2011 · AG
Cellular Interactions with the Extracellular Matrix of the Tumor Microenvironment
$377,222Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2010 · CA
ATF2 in melanoma development and progression
$377,138Mount Sinai School Of Medicine Of Nyu · R01 · FY2003 · CA
ATF2 in melanoma development and progression
$377,138Mount Sinai School Of Medicine Of Nyu · R01 · FY2004 · CA
Nanoformulated small molecule immunotherapy for SHH medulloblastoma
$377,088Marina Sokolsky-Papkov · Univ Of North Carolina Chapel Hill · R01 · FY2024 · NS
Angiogenic Factors Associated with Uveal Melanoma
$377,078Arthur S Polans · University Of Wisconsin-Madison · R01 · FY2006 · CA
Immunology of human malignant melanoma initiating cells
$377,059Markus H. Frank · Boston Children'S Hospital · R01 · FY2013 · CA
USP18 in Cancer Development
$376,989Dong-Er Zhang · University Of California, San Diego · R01 · FY2019 · CA
Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer
$376,909Peter A Cohen · Mayo Clinic Rochester · P50 · FY2016 · CA
The Unique Roles of Tumor-Specific Th9 Cells for Solid Tumor Eradication
$376,900Yong Lu · Methodist Hospital Research Institute · R01 · FY2024 · CA
ATF2 in DNA damage response.
$376,879Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · CA
Oncometabolites, DNA Repair, and Cancer
$376,875Peter M Glazer · Yale University · R01 · FY2022 · ES
Oncometabolites, DNA Repair, and Cancer
$376,875Peter M Glazer · Yale University · R01 · FY2023 · ES
Oncometabolites, DNA Repair, and Cancer
$376,875Peter M Glazer · Yale University · R01 · FY2025 · ES
Oncometabolites, DNA Repair, and Cancer
$376,875Peter M Glazer · Yale University · R01 · FY2024 · ES
Development of GenomeBuild as a Universal Method to Synthesize Genomes
$376,800Christopher L Warren · Proteovista, Llc · R43 · FY2023 · HG
The Role of JAM-C in Adhesive Interactions of Immune Cells
$376,790Triantafyllos Chavakis · Basic Sciences · Z01 · FY2007 · CA